Seasonal Allergic Rhinitis: A focused systematic review and practice parameter update

Current Opinion in Allergy and Clinical Immunology - Tập 17 Số 4 - Trang 286-294 - 2017
Dana Wallace1,2,3, Mark S. Dykewicz4,1
1Section of Allergy and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
2fax: +1 954 252 4456
3to Dana V. Wallace, MD, Associate Clinical Professor, Allopathic Medical School, Nova Southeastern University, David, FL 33312, USA. Tel: +1 954 605 6246
4Allopathic Medical School, Nova Southeastern University, David, Florida

Tóm tắt

Purpose of review The review compares and contrasts seven major United States and international allergic rhinitis guidelines from 2008 to 2017. Recent findings Despite many treatment options for allergic rhinitis, patients often report lack of therapeutic control and a reduced quality of life. Guidelines intended to improve allergic rhinitis care have been evolving into evidence based, systematic reviews, with less reliance on consensus of expert opinion characteristic of more traditional guidelines. The first Grading of Recommendations Assessment, Development, and Evaluation-based guideline developed in the United States for seasonal allergic rhinitis was first published in 2017. Summary When critically analyzing the allergic rhinitis guidelines that use the rigorous Grading of Recommendations Assessment, Development, and Evaluation methodology, different groups of expert authors, using the same reference articles, will, at times, reach different conclusions regarding the quality of the evidence and the strength of the recommendation. Factors potentially contributing to these divergent determinations include: lack of objective primary outcome measures in allergic rhinitis, poorly defined Minimal Clinically Important Difference, failure to include all interested parties in guideline development, for example, patients, and subjectivity inherent in the expert panel.

Từ khóa


Tài liệu tham khảo

Hill, 2016, The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study, BMC Pediatr, 16, 133, 10.1186/s12887-016-0673-z

Baptist, 2016, Rhinitis in the Elderly, Immunol Allergy Clin North Am, 36, 343, 10.1016/j.iac.2015.12.010

Meltzer, 2012, Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys, Allergy Asthma Proc, 33, S113, 10.2500/aap.2012.33.3603

Wallace, 2008, The diagnosis and management of rhinitis: an updated practice parameter, J Allergy Clin Immunol, 122, S1, 10.1016/j.jaci.2008.06.003

Brozek, 2010, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision, J Allergy Clin Immunol, 126, 466, 10.1016/j.jaci.2010.06.047

Seidman, 2015, Clinical practice guideline: allergic rhinitis, Otolaryngol Head Neck Surg, 152, S1

Devillier, 2014, The minimally important difference in the rhinoconjunctivitis total symptom score in grass-pollen-induced allergic rhinoconjunctivitis, Allergy, 69, 1689, 10.1111/all.12518

Barnes, 2010, The minimal clinically important difference in allergic rhinitis, Clin Exp Allergy, 40, 242, 10.1111/j.1365-2222.2009.03381.x

Meltzer, 2016, Minimal clinically important difference (MCID) in allergic rhinitis: agency for healthcare research and quality or anchor-based thresholds?, J Allergy Clin Immunol Pract, 4, 682, 10.1016/j.jaip.2016.02.006

Carr, 2012, A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis, J Allergy Clin Immunol, 129, 1282.e10, 10.1016/j.jaci.2012.01.077

Hampel, 2010, Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device, Ann Allergy Asthma Immunol, 105, 168, 10.1016/j.anai.2010.06.008

Meltzer, 2012, MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety, Allergy Asthma Proc, 33, 324, 10.2500/aap.2012.33.3587

Meltzer, 2013, Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis, Int Arch Allergy Immunol, 161, 369, 10.1159/000351404

Thông tin
Thông tin xuất bản

Current Opinion in Allergy and Clinical Immunology

Tập 17 Số 4

286-294

Thông tin tác giả